Werewolf Therapeutics Inc.
HOWL | NASDAQ
$0.98
+$0.02 (+1.55%)
At close: Sep 21, 2026, 4:00 PM ET
$0.97
-$0.01 (-0.96%)
Pre-market:
Sep 22, 2026, 8:59 AM ET
Market Data
Market Cap $47.62M
Enterprise Value $25.64M
Beta 0.29
Average Volume 632.34K
Shares Outstanding (Diluted) 48.6M
Shares Change YoY 8.04%
Institutional Ownership 28.81%
Exchange NASDAQ
ISIN US95075A1079
Price Performance
Price Change 1M 15.3%
Price Change 3M 170.9%
Price Change 6M 25.6%
Price Change YTD 52.0%
Price Change 1Y -46.7%
Price Change 3Y -55.6%
Price Change 5Y -94.5%
1M CAGR (ann.) 146.8%
1Y CAGR (ann.) -32.4%
5Y CAGR (ann.) -43.9%
All-Time CAGR -40.5%
Valuation
PE Ratio -1.34
Forward PE N/A
PEG Ratio -0.02
Forward PEG 0.04
PS Ratio 2.27
Forward PS 15.40
PB Ratio 2.92
P/FCF Ratio -1.58
P/Adj. FCF Ratio -1.40
P/OCF Ratio -1.58
EV/Sales 1.22
EV/EBIT -1.00
EV/EBITDA -1.16
EV/FCF -0.85
Earnings Yield -74.5%
FCF Yield -63.3%
Adj. FCF Yield -71.3%
Financial Health
Net Cash $21.99M
Total Debt $0
Cash & Short-Term Investments $21.99M
Total Assets $24.16M
Current Ratio 2.91
Quick Ratio 2.91
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage -5.62
Altman Z-Score -26.38
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 86.4%
Operating Profit Margin -121.8%
EBITDA Margin -104.8%
Net Profit Margin -164.8%
FCF Margin -143.6%
Adj. FCF Margin -161.6%
SBC / Revenue 18.1%
SBC Impact (per share) -12.6%
Returns
Return on Assets -143.3%
Return on Equity -167.0%
Return on Invested Capital -157.0%
Return on Capital Employed -157.0%
Return on Tangible Assets -143.3%
Historical Growth (CAGR)
Revenue CAGR 3Y -5.4%
Revenue CAGR 5Y 7.5%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 25.0%
EPS CAGR 5Y 18.2%
EPS CAGR 10Y N/A
FCF CAGR 3Y 13.2%
FCF CAGR 5Y 2.3%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 9
EPS Growth Next 3Y -11.4%
Revenue Growth Next 3Y -5.0%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) -$0.22
EPS Growth Est (next Q) -38.9%
Revenue Est (next Q) $18.31M
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $6.50
Price Target Upside 563.3%
Cash Flow
Operating Cash Flow $-30.15M
Free Cash Flow $-30.15M
Adj. Free Cash Flow $-33.94M
FCF Per Share -$0.62
OCF Per Share -$0.62
OCF/S Ratio -143.6%
Income Statement
Revenue $21M
Gross Profit $18.15M
Operating Income $-25.57M
EBITDA $-22.02M
Net Income $-34.61M
EPS (Diluted) -$0.73
Revenue / Employee $538.46K
Profit / Employee $-887.51K
Employees 39
Add to Watchlist
Select watchlists to add or remove HOWL